Annalisa Capuano
- Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions 40
-
- Diabetes Treatment and Management 30
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 12
- Pharmacology top 1%
- Drug-Induced Adverse Reactions 20
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 17
- COVID-19 Clinical Research Studies 12
-
- Pharmaceutical studies and practices 27
-
- Metabolism, Diabetes, and Cancer 19
- Co-authors
- Concetta RafanielloCristina ScavoneFrancesco RossiDario GiuglianoKatherine EspositoLiberata SportielloMaria Ida MaiorinoAnnamaria Mascolo
- Journals
- Frontiers in Pharmacology (22 papers)Pharmacological Research (20 papers)Expert Opinion on Drug Safety (14 papers)
- Partner nations
- ItalyDenmarkUnited Kingdom
In The Last Decade
Annalisa Capuano
259 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Toxicology 566
- Endocrinology, Diabetes and Metabolism 1.0k
- Geriatrics and Gerontology 230
- Pharmacology 657
- Infectious Diseases 672
Countries citing papers authored by Annalisa Capuano
This map shows the geographic impact of Annalisa Capuano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Capuano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Capuano more than expected).
Fields of papers citing papers by Annalisa Capuano
This network shows the impact of papers produced by Annalisa Capuano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Capuano. The network helps show where Annalisa Capuano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Annalisa Capuano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 30 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 24 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 32 | |
| 18 | 2020 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2016 | 4 |
About Annalisa Capuano
Annalisa Capuano is a scholar working on Toxicology, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism, having authored 266 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (40 papers), Diabetes Treatment and Management (30 papers), Pharmaceutical studies and practices (27 papers), Drug-Induced Adverse Reactions (20 papers), Metabolism, Diabetes, and Cancer (19 papers), SARS-CoV-2 and COVID-19 Research (17 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and COVID-19 Clinical Research Studies (12 papers). The work is most often cited by research in Toxicology (566 citations), Endocrinology, Diabetes and Metabolism (1.0k citations) and Geriatrics and Gerontology (230 citations). Annalisa Capuano has collaborated with scholars based in Italy, Denmark and United Kingdom. Frequent co-authors include Concetta Rafaniello, Cristina Scavone, Francesco Rossi, Dario Giugliano, Katherine Esposito, Liberata Sportiello, Maria Ida Maiorino, Annamaria Mascolo, Paolo Chiodini and Giuseppe Bellastella. Their work appears in journals such as Frontiers in Pharmacology, Pharmacological Research, Expert Opinion on Drug Safety, Pharmaceuticals and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.